Trial Profile

A phase 2 clinical trial of GH001 in patients with postpartum depression

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 25 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 5 Methoxy N N Dimethyltryptamine (Primary)
Indications Postnatal depression
Focus Proof of concept; Therapeutic Use
Sponsors GH Research

Most Recent Events

15 May 2025 According to a GH Research media release, company announces acceptance of poster has been accepted presenting data at the American Society of Clinical Psychopharmacology 2025 Annual Meeting
15 May 2025 Results presented at the GH Research media release.
08 May 2025 According to a GH Research media release, Data analysis for this trial is ongoing and further clinical trial results are expected to be provided at upcoming scientific conferences.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com